Chondroblastoma metastasis, though rare, represents a clinically significant and notably important aspect of bone tumors. Understanding its epidemiological characteristics, pathological features, and treatment modalities, despite its infrequency, is imperative for comprehensive patient management. This review aims to elucidate the epidemiology, molecular mechanisms, diagnostic challenges, and therapeutic strategies associated with chondroblastoma metastasis. The patterns, prognostic factors, and treatment outcomes were explored through an analysis of case studies and clinical reports. Notably, we highlighted emerging therapeutic perspectives aimed at improving patient outcomes. To the best of our knowledge, there has been no previous review addressing these matters cumulatively, highlighting a significant gap in the existing scholarly literature. By shedding light on the nuances of chondroblastoma metastasis, this review contributes to the advancement of knowledge in this field and informs clinical decision-making for improved patient care.
软骨母细胞瘤转移虽属罕见，却是骨肿瘤领域中具有重要临床意义的关键议题。尽管发生率较低，但全面掌握其流行病学特征、病理学特点及治疗模式对于患者的综合管理至关重要。本综述旨在系统阐述软骨母细胞瘤转移的流行病学规律、分子机制、诊断难点及治疗策略，通过分析病例研究与临床报告，深入探讨其转移模式、预后因素及治疗结果。特别值得注意的是，我们重点论述了旨在改善患者预后的新兴治疗视角。据我们所知，目前尚无综述对此议题进行系统性整合阐述，这凸显出现有学术文献中的重要空白。通过揭示软骨母细胞瘤转移的复杂特征，本综述有助于推动该领域知识体系的完善，并为优化临床决策、提升患者诊疗水平提供科学依据。
肿瘤(癌症)患者之家